Sign in
The Effect of Intravitreal Afilbercept on Perfusion Status in Patients with Retinal Vascular Disease
Jeffrey S. Heier, MD
Updates from the Field
2016
First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability
Pravin U. Dugel, MD
Annual Meeting Talks
2019
A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)
Raj K. Maturi, MD
2021
Category: AMD-Neovascular